- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04734769
Embryos With Preimplantation Genetic Testing for Aneuploidies (PGT-A) Inconclusive Result: Clinical Implications
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The main objective of assisted reproduction technologies (ART) is to achieve a healthy live newborn. The selection of an euploid embryo using PGT-A, offers theoretical advantages including increased implantation rate, reduced abortion rate, and reduces the time to achieve an ongoing pregnancy.
Certain advances in ART such as vitrification or improvement in culture media makes safer the PGT-A procedure. As a result of these improvements, embryo biopsy has been driven from blastomere to trophectoderm biopsy at blastocyst stage for preimplantional genetic testing for aneuploidy analysis (PGT-A 2.0) and it is now the method of choice for PGT-A in many centers. Trophectoderm biopsy presents advantages over the use of blastomere biopsy: 1. It allows obtaining around 6-10 cells without reducing the potential for pre-embryo development or its ability to implant. 2. Greater strength in the results, since it reduces false diagnoses associated with factors such as mosaicism. 3. It allows a combined study for monogenic mutations, aneuploidy screening and / or structural alterations.
The frequency of inconclusive results in PGT-A varies depending on the embryonic stage used, with values of 9-10% of the total embryos analyzed for single blastomere biopsy and between 2-6% when trophectoderm cells are biopsied.
These inconclusive results, mainly in couples without euploid embryos available to transfer, cause them uncertainty and disappointment. In these situations, it is advisable to guide patients in making decisions about what to do with these pre-embryos through genetic counselling. Patients must decide if they wish to reject them, to transfer them without the certainty of a reliable diagnosis or to re-analyze them. Scientific literature reporting these types of inconclusive results and that give advice about its possible etiology are scarce. There is no clear evidence about the impact of double biopsy, double vitrification-warming or if transferring embryos with inconclusive results, is safe for achieving a healthy newborn. The objective of this review is to learn from the published studies about the safety of embryo re-analysis and its potential reproductive outcome when there are embryos with inconclusive results after PGT, in order to offer adequate counselling for patients.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Elkin Muñoz
- Phone Number: 986021860
- Email: elkin.munoz@ivirma.com
Study Contact Backup
- Name: Agustina Ramos Gutierrez
- Phone Number: 986021860
- Email: agustina.ramos@ivirma.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Cycles of embryo transfer from patients with at least one euploid embryo (no rebiopsy group):
- Women age 18-45 years.
- PGT-A Indication.
- All embryos with informative results.
- Women age 18-45 years.
- PGT-A Indication.
- At least one embryo result with lack of diagnosis.
- At least one rebiopsied embryo.
- At least one euploid result from rebiopsied embryo.
- Single embryo transfer.
Exclusion Criteria:
Double embryo transfer
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Cycles of embryo transfer from patients with at least one euploid embryo (no rebiopsy group)
Collect retrospectively clinical data on reproductive outcomes
|
Collect retrospectively clinical data on reproductive outcomes
|
Rebiopsy group:
Collect retrospectively clinical data on reproductive outcomes
|
Collect retrospectively clinical data on reproductive outcomes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Implantation rate
Time Frame: Since July 2019 to December 2020
|
Analyze implantation rate in the groups
|
Since July 2019 to December 2020
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Cobo A, Castello D, Vallejo B, Albert C, de los Santos JM, Remohi J. Outcome of cryotransfer of embryos developed from vitrified oocytes: double vitrification has no impact on delivery rates. Fertil Steril. 2013 May;99(6):1623-30. doi: 10.1016/j.fertnstert.2013.01.106. Epub 2013 Feb 14.
- Chen HH, Huang CC, Cheng EH, Lee TH, Chien LF, Lee MS. Optimal timing of blastocyst vitrification after trophectoderm biopsy for preimplantation genetic screening. PLoS One. 2017 Oct 5;12(10):e0185747. doi: 10.1371/journal.pone.0185747. eCollection 2017.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011-VGO-095-EM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Embryo Disorder
-
IVI VigoInstituto Valenciano de Infertilidad, IVI VALENCIAUnknown
-
IVI VigoCompleted
-
University Hospital, GhentCompletedGenetic Disease | Embryo | Embryo DisorderBelgium
-
University Medical Centre MariborCompletedEmbryonic Development | Embryo Morphokinetics | Embryo MorphometrySlovenia
-
University Hospital Virgen de las NievesJunta de AndalucíaCompletedPregnancy Rate | Single Embryo Transfer | Embryo Implantation, DelayedSpain
-
University Hospital, ToulouseRecruitingPregnancy | Humans | Embryo Growth DisorderFrance
-
Institut Universitari DexeusTerminatedComplications; Artificial Fertilization, Introduction of Embryo in Embryo TransferSpain
-
Tang-Du HospitalUnknown
-
Li-jun DingUnknown
Clinical Trials on Collect retrospectively clinical data on reproductive outcomes
-
IVI VigoInstituto Valenciano de Infertilidad, IVI VALENCIACompleted
-
IVI VigoCompleted
-
IVI VigoInstituto Valenciano de Infertilidad, IVI VALENCIACompletedUterine Diseases
-
IVI VigoInstituto Valenciano de Infertilidad, IVI VALENCIA; IVI Madrid; Fundación IVICompleted
-
IVI VigoUnknown
-
University of OxfordSanpasitthiprasong Hospital; Mahidol Oxford Tropical Medicine Research UnitCompletedHospital-acquired InfectionsThailand
-
Peking University Third HospitalRecruitingPatellar Dislocation | Treatment | Sport Injury | Anatomic Abnormality | Trochlear Dysplasia | Femoral AnteversionChina
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Centre National...UnknownDiabetes Mellitus | Insulin-DependentFrance
-
University Hospital, BordeauxCompletedArrhythmia | SARS-CoV-2 InfectionFrance